A team of scientists at the University of California, Los Angeles (UCLA) have developed a groundbreaking cell-based ...

A new study uses single-cell transcriptomics from a 12-week clinical trial to reveal how kimchi influences the immune system. With seasonal shifts increasing the circulation of respiratory infections ...

INmune Bio, Inc. (NASDAQ: INMB) (“INmune” or the “Company”), a clinical-stage inflammation and immunology company, announces a recently published overview of future applications and research areas for ...

In this day and age, on the surface level, it seems like we know a lot about how the world, the human body, and the universe ...

The publication, titled “Prime Editing for p47-phox Chronic Granulomatous Disease,” reports initial data for two patients treated in the Phase 1/2 trial of PM359, which was designed to assess safety, ...

Incyte today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal ...

Zai Lab Limited today announced that the following medicines and indications have been renewed in the 2025 National Reimbursement Drug List (NRDL) released by China's National Healthcare Security ...

Mixed chimerism or relapses following TSC-101 infusions were found to be significantly associated with greater ex vivo expansion of TCR-T cells during the manufacturing process. A new commercial-ready ...